Ayahuasca preparations and serotonin reuptake inhibitors: A potential combination for severe adverse interactions

Journal of Psychoactive Drugs

Volumn 30, Issue 4, 1998, Pages 367-369

  Callaway, James C ^a   Grob, Charles S ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Ayahuasca; Drug interactions; Harmala alkeloids; Selective serotonin reuptake inhibitor (SSRI); Serotonin syndrome

Indexed keywords

AYAHUASCA EXTRACT; CYPROHEPTADINE; FLUOXETINE; METHYSERGIDE; MONOAMINE OXIDASE INHIBITOR; PLANT EXTRACT; SEROTONIN 1 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DRUG BINDING; DRUG EFFICACY; DRUG SAFETY; ETHNOPHARMACOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PSYCHOPHARMACOLOGY; SEROTONIN RELEASE; SEROTONIN SYNDROME;

EID: 0032415997     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.1998.10399712     Document Type: Article

References (19)

1. Blackwell, B. 1963. Hypertensive crisis due to monoamine-oxidase inhibitors. Lancet 2:849-51.
2. Callaway, J.C.; McKenna, D.J.; Grob, C.S.; Brito, G.S.; Raymons, G.S.; Poland, R.E., Andrade, E. & Mash, D.C. In press. Pharmacology of hoasca alkaloids in humans. Journal of Ethnopharmacology.
3. Callaway, J.C.; Raymon, L.P.; Hearn, W.L.; McKenna, D.J.; Grob, C.S.; Brito, G.S. & Mash, D.C. 1996. Quantitation of N, N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. Journal of Analytical Toxicology 20:492-97.
4. Callaway, J.C.; Airaksinen, M.M.; McKenna, D.J.; Brito, G.S. & Grob, C.S. 1994. Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology 116:385-87.
5. Copland, J.D. & Gorman, J.M. 1993. Detectable levels of fluoxetine metabolites after discontinuation: An unexpected serotonin syndrome. American Journal of Psychiatry 150:837.
6. Dobkin De Rios, M. 1994. Drug tourism in the Amazon. Omni January: 20.
7. Feighner, P.F.; William, B.F.; Tyler, D.L. & Nebrosky, R.J. 1990. Adverse consequences of fluoxetine-MAOI combination therapy. Journal of Clinical Psychiatry 51:222-5.
8. Goldberg, L.l. 1964. Monoamine oxidase inhibitors: Adverse reactions and possible mechanisms. Journal of the American Medical Association 190:132-38.
9. Grob, C.S.; McKenna, D.J.; Callaway, J.C.; Brito, G.S.; Neves, E.S.; Oberlaender, G.; Saide, O.L.; Labigalini, E.; Tacla, C.; Miranda, C.T.; Strassman, R.J. & Boone, K.B. 1996. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. Journal of Nervous and Mental Disease 184:8694.
10. Krajick, K. 1992. Vision quest. Newsweek June 15: 44-45.
11. Luna, L. & Amaringo, P.C. 1991. Ayahuasca Visions: The Religious Iconography of a Peruvian Shaman. Berkeley: North Atlantic Books.
12. McKenna, D.J.; Callaway, J.C. & Grob, C.S. 1998. The scientific investigation of ayahuasca: A review of past and current research. Heffler Review of Psychedelic Reseach I:65-77.
13. Neuvonen, P.J.; Pohjola-Sintonen, S.; Tacke, U. & Vuori, E. 1993. Five fatal cases of serotonin syndrome after moclobemide-clomipramine overdoses. Lancet 342:1419.
14. Ott, J. 1994. Ayahuasca Analogues: Pangaen Entheogens. Kennewick, Washington: Natural Products.
15. Ott, J. 1993. Pharmacotheon: Entheogenic Drugs, Their Plant Sources and History. Kennewick, Washington: Natural Products.
16. PDR Editors. 1996. Prozac. In: Physician’s Desk Reference, 50th Ed. Oradell, New Jersey: Medical Economics.
17. Peterson, G.N. 1991. Strategies for fluoxetine-MAOI combination therapy. Journal of Clinical Psychiatry 52:87-8.
18. Schultes, R.E. & Hofmann, A. 1992. Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers. Rochester, Vermont: Healing Arts Press.
19. Stemback, H. 1991. The serotonin syndrome. American Journal of Psychiatry 148:705-13.